Abstract
This work presents a recently-patented small arms concept demonstrator that substantially reduces the recoil force transmitted to the user during operation. In live-fire tests, this invention produced recoil forces that were approximately 84% to 91% less than those produced by the M240 machine gun. To achieve such recoil force reduction, this invention includes design features to reduce the propellant gas contribution to recoil force and cancel the moving internal component contribution to recoil force.
Keywords: Gun, inertia, mechanism, momentum, recoil reduction, small arms
Recent Patents on Mechanical Engineering
Title:A Concept Demonstrator for Small Arms Recoil Reduction
Volume: 6 Issue: 2
Author(s): Kevin Russell
Affiliation:
Keywords: Gun, inertia, mechanism, momentum, recoil reduction, small arms
Abstract: This work presents a recently-patented small arms concept demonstrator that substantially reduces the recoil force transmitted to the user during operation. In live-fire tests, this invention produced recoil forces that were approximately 84% to 91% less than those produced by the M240 machine gun. To achieve such recoil force reduction, this invention includes design features to reduce the propellant gas contribution to recoil force and cancel the moving internal component contribution to recoil force.
Export Options
About this article
Cite this article as:
Russell Kevin, A Concept Demonstrator for Small Arms Recoil Reduction, Recent Patents on Mechanical Engineering 2013; 6 (2) . https://dx.doi.org/10.2174/2212797611306020006
DOI https://dx.doi.org/10.2174/2212797611306020006 |
Print ISSN 2212-7976 |
Publisher Name Bentham Science Publisher |
Online ISSN 1874-477X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Immunomodulator Activity of 3-Hydroxy-3-Methilglutaryl-CoA Inhibitors
Cardiovascular & Hematological Agents in Medicinal Chemistry Molecular Genetic Approaches for Studying the Etiology of Diabetic Nephropathy
Current Molecular Medicine Nutraceutical Targeting of Placental Synthesis of Soluble Fms-Like Tyrosine Kinase- 1 (sFlt-1) as Strategy for Preventing and Controlling Pre-eclampsia
Current Pharmaceutical Design Physiological Effect and Therapeutic Application of Alpha Lipoic Acid
Current Medicinal Chemistry Structure and Function of Poly(ADP-ribose) Polymerase-1: Role in Oxidative Stress-Related Pathologies
Current Vascular Pharmacology Current Concepts in Adult Stem Cell Therapy for Stroke
Current Medicinal Chemistry Safety and Efficacy of Thioridazine as Salvage Therapy in Indian Patients with XDR-TB
Recent Patents on Anti-Infective Drug Discovery New Approaches to the Modulation of the Cyclooxygenase-2 and 5-Lipoxygenase Pathways
Current Topics in Medicinal Chemistry Oxytocin as a Potential Adjuvant Against COVID-19 Infection
Endocrine, Metabolic & Immune Disorders - Drug Targets Patent Review on Network-based Elderly Healthcare System in the US
Recent Patents on Computer Science Mutations of Mitochondrial DNA in Atherosclerosis and Atherosclerosis-Related Diseases
Current Pharmaceutical Design Understanding the Potential Role and Delivery Approaches of Nitric Oxide in Chronic Wound Healing Management
Current Pharmaceutical Design From Mind to Body: Is Mental Practice Effective on Strength Gains? A Meta-Analysis
CNS & Neurological Disorders - Drug Targets Seeking the Active Site of the AT1 Receptor for Computational Docking Studies
Drug Design Reviews - Online (Discontinued) Selective Cyclooxygenase Inhibitors: Current Status
Current Drug Discovery Technologies Towards Isozyme-Selective HDAC Inhibitors For Interrogating Disease
Current Topics in Medicinal Chemistry Meet Our Editorial Board Member
Current Cardiology Reviews Kynurenine Pathway and Disease: An Overview
CNS & Neurological Disorders - Drug Targets The Significance of Renal Function in Response to Cardiac Resynchronisation Therapy – A Piece of a Much Larger Puzzle
Current Vascular Pharmacology Glucocorticoid-Induced Hypertension and Tetrahydrobiopterin (BH4), a Common Cofactor for the Production of Vasoactive Molecules
Current Hypertension Reviews